Abstract
Despite combination antiretroviral therapy (ART), HIV infected people have higher mortality than non-infected. Lower socioeconomic status (SES) predicts higher mortality in many chronic illnesses but data in people with HIV is limited. We evaluated 878 HIV infected individuals followed from 1995 to 2005. Cox proportional hazards for all-cause mortality were estimated for SES measures and other factors. Mixed effects analyses examined how SES impacts factors predicting death. The 200 who died were older, had lower CD4 counts, and higher viral loads (VL). Age, transmission category, education, albumin, CD4 counts, VL, hunger, and poverty predicted death in univariate analyses; age, CD4 counts, albumin, VL, and poverty in the multivariable model. Mixed models showed associations between (1) CD4 counts with education and hunger; (2) albumin with education, homelessness, and poverty; and (3) VL with education and hunger. SES contributes to mortality in HIV infected persons directly and indirectly, and should be a target of health policy in this population.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10461-010-9759-z/MediaObjects/10461_2010_9759_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10461-010-9759-z/MediaObjects/10461_2010_9759_Fig2_HTML.gif)
Similar content being viewed by others
References
Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365(9458):493–500.
Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.
Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.
Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.
Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.
Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.
Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol. 1998;148(3):282–91.
Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy Lazio AIDS Surveillance Collaborative Group. Epidemiol Cambridge Mass. 2000;11(5):496–501.
Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr. 2002;30(1):111–8. (May 1).
Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120–4.
Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol. 1994;47(1):59–67.
McDavid Harrison K, Ling Q, Song R, Hall HI. County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol. 2008;18(12):919–27.
McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003;33(1):96–103. (May 1).
Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72. (Oct 18).
Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5. (Apr 1).
Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved. 2005;16(4):655–76.
Forrester JE, Spiegelman D, Woods M, Knox TA, Fauntleroy JM, Gorbach SL. Weight and body composition in a cohort of HIV-positive men and women. Public Health Nutr. 2001;4(3):743–7.
Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.
Poverty Thresholds since 1980. United States Census Bureau; 2009 [June 2 2009]; Available from: http://www.census.gov/hhes/www/poverty/threshld.html.
General definition of homeless individual. 42 USC Sec. 11302 Office of the Law Revision Counsel, U.S. House of Representatives; 2007 [June 4 2009]; Available from: http://uscode.house.gov/uscode-cgi/fastweb.exe?getdoc+uscview+t41t42+7022+23++(11302).
Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544–8.
Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793–801.
Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775–89.
Who is currently living with HIV/AIDS?—Detailed data tables and technical notes: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
Massachusetts HIV/AIDS Data Fact Sheet. Who is most at risk of HIV infection?: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
2007 Rhode Island HIV/AIDS Epidemiologic Profile With Surrogate Data: Rhode Island Department of Health. Division of Community Family Health and Equity. Office of HIV/AIDS & Viral Hepatitis August 2008.
Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women’s interagency HIV study. AIDS. 1999;13(13):1717–26.
Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr. 2003;33(1):66–73. (May 1).
Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872–80.
Overview of the Census of Population: A brief history. Statistics Canada; 2009 [June 11 2009]; Available from: http://www12.statcan.ca/english/census06/reference/dictionary/ovpop1b.cfm#dece.
What is the Census? : United States Census Bureau; 2009 [June 11 2009]; Available from: http://2010.census.gov/2010census/.
Data banks and information systems. Roma: Istat - Istituto nazionale di statistica; 2009 [June 11 2009]; Available from: http://www.istat.it/english/databanks.html.
Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS reports. 2007;4(4):181–6.
Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006;22(1):14–21.
Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–54.
Mason JB. Nutritional Assessment and Management of the Malnourished Patient,Eighth ed. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W B Saunders Company; 2006.
Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS care. 2004;16(Suppl 1):S22–42.
Diaz T, Chu SY, Buehler JW, Boyd D, Checko PJ, Conti L, et al. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994;10(4):217–22.
Hankins C, Tran T, Hum L, Laberge C, Lapointe N, Lepine D, et al. Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989–1993. Int J Epidemiol. 1998;27(4):691–7.
Zierler S, Krieger N, Tang Y, Coady W, Siegfried E, DeMaria A, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.
El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.
Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.
The Ryan White HIV/AIDS Program. U.S. Department of Health and Human Services. Health Resources and Services Administration; 2009 [June 12 2009]; Available from: http://hab.hrsa.gov/about/.
Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama. 1998;280(6):547–9.
Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–73.
Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18(13):1835–43.
Fox CS, Evans JC, Larson MG, Lloyd-Jones DM, O’Donnell CJ, Sorlie PD, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95(7):856–9.
Acknowledgments
We wish to thank the participants and investigators of the Nutrition for Healthy Living cohort for their time and enthusiasm.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Institutes of Health grants R01 HL 65947, P30 DA13868, P30 AI42853, and P01 DK45734.
Rights and permissions
About this article
Cite this article
McMahon, J., Wanke, C., Terrin, N. et al. Poverty, Hunger, Education, and Residential Status Impact Survival in HIV. AIDS Behav 15, 1503–1511 (2011). https://doi.org/10.1007/s10461-010-9759-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-010-9759-z